Australia markets open in 5 hours 15 minutes

Surgery Partners, Inc. (SGRY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
34.13-1.28 (-3.61%)
As of 12:44PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close35.41
Open34.89
Bid34.01 x 1100
Ask34.12 x 900
Day's range33.75 - 35.32
52-week range20.46 - 63.87
Volume193,338
Avg. volume908,672
Market cap4.184B
Beta (5Y monthly)2.71
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Surgery Partners, Inc. Reaffirms 2022 Full Year Guidance

    BRENTWOOD, Tenn., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Members of management of Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, will be meeting with investors today, January 9, 2023, as part of the 41st Annual J.P. Morgan Healthcare Conference, including a presentation at 8:15 p.m. ET. Based on results through November 2022, the Company is re-affirming its 2022 Adjusted EBITDA guidance of $375 million to $385 mil

  • GlobeNewswire

    Surgery Partners, Inc. To Present At Upcoming Investor Conference

    BRENTWOOD, Tenn., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced that Wayne S. DeVeydt, Executive Chairman of the Board, Eric Evans, Chief Executive Officer and Dave Doherty, Chief Financial Officer will meet with investors at the J.P. Morgan Healthcare Conference, including a presentation on Monday, January 9, 2023 at 8:15p.m. (Eastern Time). Interested inves

  • GlobeNewswire

    Surgery Partners, Inc. Announces Pricing of Upsized $575 Million Public Offering of Common Stock and $225 Million Concurrent Private Placement to Bain Capital

    BRENTWOOD, Tenn., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners”) today announced the pricing of its upsized underwritten public offering of $575 million of its common stock at a public offering price of $24.50 per share. Gross proceeds to Surgery Partners from the offering are expected to be approximately $575 million, before deducting underwriting discounts and commissions and other offering expenses payable by Surgery Partners. In addition, Surgery